Clinical Trials Search at Vanderbilt-Ingram Cancer Center

VANISH 2- Ventricular Tachycardia Antiarrhythmics or Ablation in Structural Heart Disease 2

Disease Sites:

Not Available

Staging:

Phase III

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Kanagasundram, Arvindh

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

09-10-2018

Trial Type:

Treatment

Protocol ID:

CRE-CHF0001

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available